Position history for HARDING LOEVNER LP's holdings in VERTEX PHARMACEUTICALS INC
HARDING LOEVNER LP holds 313,546 shares of VRTX (VERTEX PHARMACEUTICALS INC), worth $140M as of 2026-Q1. The position was decreased (-20.0% shares). VRTX represents 1.4% of HARDING LOEVNER LP's portfolio.
Current Value
$140M
Current Shares
313,546
Total Value Change
-$415.2M
Total Shares Change
-870,862
Other major holders of VRTX: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Decreased |
| 313,546 |
-20.0% |
| $140M |
| 1.4% |
| $474.27 |
0 |
| 2025-Q4 | Decreased | 391,865 | -14.1% | $177.7M | 1.6% | $453.74 | 0 |
| 2025-Q3 | Decreased | 455,988 | -35.9% | $178.6M | 1.3% | $395.31 | 0 |
| 2025-Q2 | Increased | 711,611 | +1.9% | $316.8M | 2.1% | $441.30 | 54 |
| 2025-Q1 | Decreased | 698,459 | -15.2% | $338.6M | 2.6% | $492.69 | 0 |
| 2024-Q4 | Decreased | 823,627 | -28.5% | $331.7M | 2.2% | $399.35 | 0 |
| 2024-Q3 | Decreased | 1.2M | -2.7% | $536.1M | 3.1% | $462.88 | 0 |
| 2024-Q2 | Decreased | 1.2M | -3.2% | $555.2M | 3.1% | $468.72 | 0 |